Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,388,814
New position
Shares Held
24,103
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#991
of 2,506 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026F/m Investments LLC holds $52,996,280 across 11 Drug Manufacturers - General names. BMY ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,561 | $29,459,202 | |
| 2 | JNJ |
Johnson & Johnson
|
39,177 | $9,949,782 | |
| 3 | ABBV |
AbbVie Inc.
|
24,521 | $6,170,464 | |
| 4 | AMGN |
Amgen Inc
|
4,809 | $1,741,435 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
24,103 | $1,388,814 | |
| 6 | PFE |
Pfizer Inc
|
47,630 | $1,146,930 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,674 | $986,109 | |
| 8 | GSK |
GSK plc
|
15,772 | $826,768 |
All Filings in BMY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,388,814 | 24,103 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||